Xconomy’s Digital Events →
Headshot of Ed Hurwitz, chairman of BioIntervene and managing director at MPM Capital. Photo used courtesy of BioIntervene.
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
From Our Editors · Podcast
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.